Mark R. Melilli

Cell & Gene Therapy Advanced Manufacturing Lead, Vertex Pharmaceuticals

Mark Melilli is a Chemical Engineer who has been working in the Biotech industry for 12 years including biologics, autologous cell therapy, allogenic cell therapy, gene editing, and gene therapy. Mark has been involved with the facility design and construction for various cell and gene therapy clinical manufacturing as a design engineer, CQV engineer, and project engineer. In his current role he is responsible for bringing small scale Cell & Gene therapy treatments to larger populations as Vertex builds out Phase 3 and Commercial Manufacturing.